1. EXOREX® (100% EQUIVALENT TO LINOTAR®) IS SUPERIOR TO A CONVENTIONAL 5% COAL TAR
Exorex Lotion 1% (= Linotar Gel 1%) is superior to a conventional coal tar lotion (5%) for treatment of mild to moderate psoriasis, and may be preferred as a first-line topical treatment, according to a study published in the 2003 issue of the Journal of Dermatological Treatment.
These are the key results of this clinical study:
- Exorex (Linotar) is superior to a conventional coal tar lotion in treating psoriasis.
- Exorex (Linotar) may be the preferred option for first-line topical treatment.
- Doctors’ and patients’ assessments showed a preference for using Exorex.
- Exorex (Linotar) is well tolerated and produced fewer skin reactions.
- Exorex (Linotar) was cosmetically acceptable to patients.
Conclusion:
Based on these results the study concluded that Exorex Lotion 5% ww (Linotar Gel 1%) is significantly more effective than a conventional coal tar lotion in mild to moderate psoriasis and may be preferred for first-line topical treatment.
Reference:
Journal of Dermatological Treatment (2003) 14, 1-9.
2. EXOREX® (LINOTAR®) IS AS EFFECTIVE AS CALCIPOTRIOL (DOVONEX®, DAIVONEX®)
Exorex (Linotar) has been found to be as effective as Calcipotriol (Dovonex®, Daivonex®) in treating psoriasis in a study published in the August 2003 issue of the British Journal of Dermatology.
These are the key results of this clinical study:
– Exorex (Linotar) is as effective as Dovonex (Daivonex®) in treating psoriasis.
– Exorex (Linotar) provided the same length of psoriasis remission as Dovonex® (Daivonex®) .
– The cosmetic properties of Exorex® (Linotar®) were greatly improved over other coal tar products.
– Exorex® (Linotar®) is several times less expensive than Dovonex® (Daivonex®).
Conclusion:
Based on these results the study concluded that Exorex® (Linotar®) is a very useful alernative topical treatment for chronic moderate-to-severe plaque type psoriasis.
Reference:
British Journal of Dermatology 2003; 149: 350-353.
临床研究总结
Exorex优于传统煤焦油乳液
Exorex优于传统的煤焦油乳液（5％），用于治疗轻度至中度牛皮癣，根据20003年發佈在皮肤病治疗杂志的研究, Exorex是作为第一线的局部治疗药物的首选。
这些是本临床研究的主要结果：
1. Exorex在治疗牛皮癣是优于传统煤焦油制剂。
2. Exorex可能是一线局部治疗药物的首选。
3.医生和病人的评估表示, 偏爱使用Exorex。
4. Exorex有很好的接受性和产生较少的皮肤反应。
5. Exorex是病人可以接受的化妆品。
结论：
基于这些结果，研究的结论是Exorex是比传统煤焦油乳液明显有效, 在针对轻度至中度牛皮癬更有效，可能是一线局部治疗药物的首选。
参考文献：皮肤病杂志的治疗（2003年）14，1-9。
Exorex效果和Dovonex（Daivonex）一樣有效。
Exorex已发现和Dovonex（Daivonex）治疗牛皮癣一样有效，发表在2003年8月英国皮肤科杂志发的一项研究。
这些都是本次临床研究的主要结果：
1. Exorex治疗牛皮癣和Dovonex一样有效。
2. Exorex提供牛皮癣缓解作用和Dovonex的时间长度相同。
3. Exorex的化妆品性质比其他煤焦油产品进步很多。
4. Exorex比Dovonex（Daivonex）便宜好几倍。
结论：
基于这些结果，研究的结论是Exorex对治疗局部慢性、中度至重度斑块型牛皮癣非常有用。
参考文献：2003英国皮肤病学杂志; 149：350-353
